Trial NCT01015677

View at ClinicalTrials.gov 
Org. Study IDs: 6913-004
Secondary IDs: MK-6913-004

Last trial update was posted on 2018-08-31

MeSH Interventions

Estradiol Estradiol 17 beta-cypionate Estradiol 3-benzoate Polyestradiol phosphate

MeSH Conditions


Other Conditions

Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated at the end of Stage 1 so no participants entered Stage 2 and no participants received MK-6913 25 mg.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID